Pharmabiz

Oral semaglutide for weight loss could be a game-changer for obesity care in India

Oral semaglutide for weight loss could be a game-changer for obesity care in India: Our Bureau, Mumbai Thursday, December 11, 2025, 15:30 Hrs [IST] New findings presented at Obesi ...
Pharmabiz

Antimalarial product development partnership, MMV joins iiCON consortium

Antimalarial product development partnership, MMV joins iiCON consortium: Liverpool, UK Thursday, December 11, 2025, 15:00 Hrs [IST] The antimalarial product development partnersh ...
Pharmabiz

IIT Bombay's TIH-IoT all set to host ATMAN 3.0 for early-stage healthtech startups

IIT Bombay's TIH-IoT all set to host ATMAN 3.0 for early-stage healthtech startups: Our Bureau, Mumbai Thursday, December 11, 2025, 14:30 Hrs [IST] The Technology Innovation Hub f ...
Pharmabiz

Quanterix-Lucent & Emocog enter exclusive Korea distribution agreement for Simoa platform for blood-based Alzheimer’s diagnostics

Quanterix-Lucent & Emocog enter exclusive Korea distribution agreement for Simoa platform for blood-based Alzheimer’s diagnostics: Seoul, Republic of Korea Thursday, December 11 ...
Pharmabiz

Maarga Mind Care expand to Gurgaon, targets 25 mental health hospitals across India by 2030

Maarga Mind Care expand to Gurgaon, targets 25 mental health hospitals across India by 2030: Our Bureau, Bengaluru Thursday, December 11, 2025, 14:15 Hrs [IST] Maarga Mind Care, a ...
Pharmabiz

Gilead Foundation awards over $3 million to support people living with metastatic breast cancer

Gilead Foundation announced a commitment of more than $3 million in new grants to help address critical gaps in education, care delivery and support services for people affected by metastatic breast ...
Pharmabiz

Arrowhead Pharma doses first subjects in phase 1/2a study of ARO-MAPT to treat Alzheimer’s disease and other tauopathies

Arrowhead Pharma doses first subjects in phase 1/2a study of ARO-MAPT to treat Alzheimer’s disease and other tauopathies: Pasadena, California Thursday, December 11, 2025, 12:00 ...
Pharmabiz

Polpharma Biologics and Libbs Farmacêutica ink licensing agreement for biosimilar for autoimmune diseases in Brazilian market

Polpharma Biologics and Libbs Farmacêutica ink licensing agreement for biosimilar for autoimmune diseases in Brazilian market: Switzerland Thursday, December 11, 2025, 11:00 Hrs ...
Pharmabiz

Pharmexcil announces election for one-third of the members of the CoA for 2025–26

Pharmexcil announces election for one-third of the members of the CoA for 2025–26: Shardul Nautiyal, Mumbai Thursday, December 11, 2025, 12:10 Hrs [IST] In line with Articles 24 ...
Pharmabiz

US FDA grants Orphan Drug Designation to GSK’227, a B7-H3-targeted antibody-drug conjugate to treat small-cell lung cancer

US FDA grants Orphan Drug Designation to GSK’227, a B7-H3-targeted antibody-drug conjugate to treat small-cell lung cancer: London, UK Thursday, December 11, 2025, 09:00 Hrs [IS ...
Pharmabiz

WHO & European Commission’s HERA sign €3.5 mn agreement to expand partnership to combat antimicrobial resistance under EU4Health programme

WHO & European Commission’s HERA sign €3.5 mn agreement to expand partnership to combat antimicrobial resistance under EU4Health programme: Geneva Thursday, December 11, 2025, ...
Pharmabiz

Only 192 applications approved under RPTUAS to upgrade existing units to revised Schedule M standards

Only 192 applications approved under RPTUAS to upgrade existing units to revised Schedule M standards: Gireesh Babu, New Delhi Thursday, December 11, 2025, 08:00 Hrs [IST] Even as ...